Selected Quarterly Financial Data (unaudited) - Summary of Selected Quarterly Financial Data (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Condensed Financial Statements, Captions [Line Items]
Additional paid-in-capital	$ 172,212	$ 170,241
Accumulated deficit	133,427	94,151
Research and development expenses	25,680	41,564
General and administrative Expenses	14,881	15,252
Total operating expenses	40,561	56,816
Net income (loss)	$ (39,276)	$ (38,422)
Weighted average shares used to compute net loss (income) per share, basic	40,254,890	37,558,464
Weighted average shares used to compute net loss (income) per share, fully diluted	40,254,890	37,558,464
Net income (loss) per common share, basic	$ (0.98)	$ (1.02)
Net income (loss) per common share, diluted	$ (0.98)	$ (1.02)